Ann Pace
Ann Pace is a scientific research organizational leader. Ann started her career as a pharmaceutical scientist at Pfizer Central Research in Connecticut, working on dosage form development. Her Ph.D. in Cellular and Molecular Pharmacology at UC San Francisco focussed on studying how specific genetic changes lead to tumor growth. She performed research in signal transduction using functional genomics approaches as an NIH postdoctoral scholar at Stanford University. Ann went on to work in gene discovery, sequencing and bioinformatic analysis at a Silicon Valley biotech firm before returning to academia to help start and lead several new endeavors at UC Santa Cruz including the Center for Biomolecular Science and Engineering (CBSE), the California Institute for Quantitative Biosciences (QB3), the Institute for the Biology of Stem Cells (IBSC), and the Genomics Institute (GI).
